| Line 63: | Line 63: | ||
*4.3 million US adult nicotine vapers are ex-smokers. | *4.3 million US adult nicotine vapers are ex-smokers. | ||
*[https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6946a4-H.pdf PDF Version] | *[https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6946a4-H.pdf PDF Version] | ||
===2018: [https://onlinelibrary.wiley.com/doi/10.1111/add.14527 Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey]=== | |||
*Despite the need for more evidence on their efficacy and long‐term safety, NVPs are now a more popular method for cessation than licensed NRT and prescription stop‐smoking medications in many countries. | |||
*In light of this, HPs should be prepared to provide balanced information about NVPs, particularly to smokers who are unable to stop smoking with approved cessation therapies, and for those who are requesting guidance regarding NVPs as a smoking cessation aid | |||
*Overall, the results from this study have shown that discussions between smokers and HPs about both quitting smoking, and the possible role NVPs could play as a cessation aid, were infrequent in the four countries in 2016. This may represent a lost opportunity for encouraging quitting smoking by providing a potentially attractive option to help smokers to quit. | |||
*[https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.14527 PDF Version] | |||
<br> | <br> | ||
edits